Diferencia entre revisiones de «EBQ:CRASH-2 Trial»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
{{info | {{JC info | ||
| title=Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage | | title=Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage | ||
| abbreviation=CRASH-2 | | abbreviation=CRASH-2 | ||
| Línea 13: | Línea 13: | ||
| fulltexturl=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext | | fulltexturl=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext | ||
| pdfurl=http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf | | pdfurl=http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf | ||
}} | |||
==Clinical Question== | ==Clinical Question== | ||
Revisión del 02:52 5 ene 2014
incomplete Journal Club Article
Shakur H, et al. "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage". The Lancet. 2010. 376(9734):23-32.
PubMed Full text PDF
PubMed Full text PDF